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Background: Human plasma low-density lipoprotein (LDL) can be chromatographically resolved into subfractions L1-L5. L5 is the most 
electronegative, atherogenic subfraction; L1 is the most abundant, harmless subfraction. To examine L5’s role in acute myocardial infarction (AMI), 
we measured the plasma L5 concentration ([L5]) in healthy (control) and metabolic syndrome (MetS) individuals without coronary artery disease 
(CAD) and in CAD patients with or without AMI.
Methods: Plasma LDL was isolated from adult control, MetS, and CAD (n=10 each) subjects and was resolved into L1-L5 by anion-exchange 
chromatography. [L5] was calculated by multiplying L5/LDL% by the LDL cholesterol (LDL-C) concentration. We compared the effects of L5 and L1 
on acute atherothrombotic responses in cultured human coronary artery endothelial cells (HCAECs).
Results: Although plasma LDL-C was similar among control, MetS, and CAD groups (93±10, 117±12, and 101±110 mg/dL, respectively; P=0.271), 
the percentages of L5 were 6±2%, 19±4%, and 43±10% (P=0.001), making [L5] 6±3, 21±4, and 46±14 mg/dL (P=0.002), respectively. No control 
or MetS individuals were taking lipid-lowering drugs, but 6/10 CAD patients were treated with statins. Among the CAD patients, 4 were asymptomatic, 
and 6 presented with AMI (5 STEMI, 1 NSTEMI). In the AMI patients, the L5/LDL% and [L5] were as high as 66±5% and 71±10 mg/dL, respectively, 
in plasma with an LDL-C concentration of 103±15 mg/dL. L5 (100 μg/mL, equivalent to 10 mg/dL in the plasma) from AMI patients not only 
induced apoptosis, but also increased the expression of C-reactive protein, P-selectin, tissue factor, and von Willebrand factor by 2 to 3-fold in 
HCAECs, whereas L1 had no effect (n=6; P<0.01). Treatment of HCAECs with L5 but not L1 increased platelet adhesion by 5-fold (P<0.001). Only L5 
particles formed large aggregates, as seen on deconvolution and cryo-electron microscopes.
Conclusions: In the absence of elevated LDL-C concentration, L5/LDL%, and hence [L5], surged in AMI patients, regardless of statin treatment. 
These highly negatively charged LDL particles form aggregates and induce multiple inflammatory changes in HCAECs that promote platelet adhesion 
and aggregation.
